Innovations to Impact

A biopharmaceutical startup spun out of UB, pioneering a novel drug class aimed at preventing the delivery of anticancer toxins to healthy cells.

The life sciences company tackles implant infections with disruptive UB technology.

A national reference laboratory scales up diagnostics with funding, equipment and expertise from UB.

Innovative therapies developed at UB target devastating diseases like cancer.

High-tech facilities and support from UB expedite diagnostic testing.

Computerized simulation and UB technology help reduce the spread of COVID-19.